The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.
Saved in:
| Title: | The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy. |
|---|---|
| Authors: | Muntoni, Francesco1,2 (AUTHOR), Byrne, Barry J.3 (AUTHOR), McMillan, Hugh J.4 (AUTHOR), Ryan, Monique M.5 (AUTHOR), Wong, Brenda L.6 (AUTHOR), Dukart, Juergen7,8 (AUTHOR), Bansal, Amita9 (AUTHOR), Cosson, Valerie9 (AUTHOR), Dreghici, Roxana9,10 (AUTHOR), Guridi, Maitea9 (AUTHOR), Rabbia, Michael11 (AUTHOR), Staunton, Hannah12 (AUTHOR), Tirucherai, Giridhar S.13 (AUTHOR), Yen, Karl11,14 (AUTHOR), Yuan, Xiling13 (AUTHOR), Wagner, Kathryn R.9,15 (AUTHOR) kathrynraewagner@gmail.com, the Taldefgrobep Alfa Study Group (AUTHOR), Carvajal, Irvith (AUTHOR), Chimalakonda, Anjaneya (AUTHOR), Gokemeijer, Jochem (AUTHOR) |
| Source: | Neurology & Therapy. Feb2024, Vol. 13 Issue 1, p183-219. 37p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
